PDB Short entry for 1AP7 HEADER CELL CYCLE INHIBITOR 25-JUL-97 1AP7 TITLE P19-INK4D FROM MOUSE, NMR, 20 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: P19-INK4D; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CYCLIN DEPENDENT KINASE 4 INHIBITOR D; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 CELL_LINE: BL21; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: FUSED TO 5' END OF GLUTATHIONE-S- SOURCE 10 TRANSFERASE GENE; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PGEX 2T; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: BL21 KEYWDS CELL CYCLE INHIBITOR, CYCLIN DEPENDENT KINASE INHIBITOR, INK, CDKI, KEYWDS 2 ANKYRIN REPEAT EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.J.ARCHER,F.Y.LUH,P.J.DOMAILLE,B.O.SMITH,E.D.LAUE REVDAT 3 16-FEB-22 1AP7 1 REMARK SEQADV REVDAT 2 24-FEB-09 1AP7 1 VERSN REVDAT 1 16-SEP-98 1AP7 0 JRNL AUTH F.Y.LUH,S.J.ARCHER,P.J.DOMAILLE,B.O.SMITH,D.OWEN, JRNL AUTH 2 D.H.BROTHERTON,A.R.RAINE,X.XU,L.BRIZUELA,S.L.BRENNER, JRNL AUTH 3 E.D.LAUE JRNL TITL STRUCTURE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P19INK4D. JRNL REF NATURE V. 389 999 1997 JRNL REFN ISSN 0028-0836 JRNL PMID 9353127 JRNL DOI 10.1038/40202 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN THE REMARK 3 JRNL CITATION ABOVE. REMARK 4 REMARK 4 1AP7 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171087. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : 100MM NACL, 1MM EDTA, 5MM DTT REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 20MM SODIUM PHOSPHATE REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D N13 NOESY; 4D N15 NOESY; 3D REMARK 210 C13 NOESY; 4D C13 NOESY; 3D HNHA REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AMX600 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : AZARA, ANSIG, XPLOR, PIPP, REMARK 210 NMRPIPE REMARK 210 METHOD USED : XPLOR SA WITH AMBIGUOUS REMARK 210 RESTRAINTS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 30 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST ENERGY STRUCTURES WITH NO REMARK 210 VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR REMARK 210 SPECTROSCOPY ON 13C, 15N-LABELED P19INK4D. ADDITIONAL RESTRAINTS REMARK 210 WERE DETERMINED FROM NMR ON 2H, 15N-LABELED P19INK4D AND REMARK 210 SELECTIVELY LABELED P19INK4D. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 DBREF 1AP7 A 3 168 UNP Q60773 CDN2D_MOUSE 1 166 SEQADV 1AP7 ALA A 18 UNP Q60773 ARG 16 CONFLICT SEQRES 1 A 168 GLY SER MET LEU LEU GLU GLU VAL CYS VAL GLY ASP ARG SEQRES 2 A 168 LEU SER GLY ALA ALA ALA ARG GLY ASP VAL GLN GLU VAL SEQRES 3 A 168 ARG ARG LEU LEU HIS ARG GLU LEU VAL HIS PRO ASP ALA SEQRES 4 A 168 LEU ASN ARG PHE GLY LYS THR ALA LEU GLN VAL MET MET SEQRES 5 A 168 PHE GLY SER PRO ALA VAL ALA LEU GLU LEU LEU LYS GLN SEQRES 6 A 168 GLY ALA SER PRO ASN VAL GLN ASP ALA SER GLY THR SER SEQRES 7 A 168 PRO VAL HIS ASP ALA ALA ARG THR GLY PHE LEU ASP THR SEQRES 8 A 168 LEU LYS VAL LEU VAL GLU HIS GLY ALA ASP VAL ASN ALA SEQRES 9 A 168 LEU ASP SER THR GLY SER LEU PRO ILE HIS LEU ALA ILE SEQRES 10 A 168 ARG GLU GLY HIS SER SER VAL VAL SER PHE LEU ALA PRO SEQRES 11 A 168 GLU SER ASP LEU HIS HIS ARG ASP ALA SER GLY LEU THR SEQRES 12 A 168 PRO LEU GLU LEU ALA ARG GLN ARG GLY ALA GLN ASN LEU SEQRES 13 A 168 MET ASP ILE LEU GLN GLY HIS MET MET ILE PRO MET HELIX 1 1 GLY A 11 ARG A 20 1 10 HELIX 2 2 VAL A 23 HIS A 31 1 9 HELIX 3 3 ALA A 47 VAL A 50 1 4 HELIX 4 4 PRO A 56 GLN A 65 1 10 HELIX 5 5 PRO A 79 THR A 86 1 8 HELIX 6 6 LEU A 89 HIS A 98 1 10 HELIX 7 7 PRO A 112 GLU A 119 1 8 HELIX 8 8 SER A 123 PRO A 130 1 8 HELIX 9 9 PRO A 144 GLN A 150 1 7 HELIX 10 10 LEU A 156 MET A 164 1 9 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000